Griffin M Weber, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electronic Health Records | 19 | 2023 | 4879 | 1.360 |
Why?
|
| Information Storage and Retrieval | 9 | 2024 | 831 | 1.100 |
Why?
|
| Computer Communication Networks | 3 | 2014 | 295 | 0.800 |
Why?
|
| Cell Biology | 2 | 2021 | 92 | 0.740 |
Why?
|
| Medical Record Linkage | 3 | 2021 | 286 | 0.700 |
Why?
|
| Cells | 1 | 2021 | 166 | 0.700 |
Why?
|
| Atlases as Topic | 1 | 2021 | 248 | 0.690 |
Why?
|
| Software | 8 | 2024 | 4480 | 0.550 |
Why?
|
| Biomedical Research | 10 | 2024 | 3463 | 0.530 |
Why?
|
| Clinical Laboratory Techniques | 2 | 2018 | 749 | 0.480 |
Why?
|
| Search Engine | 2 | 2015 | 142 | 0.470 |
Why?
|
| Algorithms | 13 | 2023 | 14199 | 0.430 |
Why?
|
| Cell Lineage | 2 | 2021 | 2576 | 0.410 |
Why?
|
| Privacy | 4 | 2022 | 233 | 0.400 |
Why?
|
| Models, Organizational | 1 | 2015 | 548 | 0.380 |
Why?
|
| Data Collection | 3 | 2023 | 3322 | 0.360 |
Why?
|
| Intracranial Hemorrhages | 5 | 2023 | 811 | 0.350 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2542 | 0.340 |
Why?
|
| Hospital Shared Services | 1 | 2009 | 16 | 0.340 |
Why?
|
| Internet | 7 | 2015 | 3112 | 0.330 |
Why?
|
| Medical Records Systems, Computerized | 2 | 2013 | 1196 | 0.330 |
Why?
|
| Pandemics | 3 | 2022 | 8745 | 0.280 |
Why?
|
| Information Dissemination | 4 | 2021 | 1141 | 0.280 |
Why?
|
| Hospital Information Systems | 1 | 2009 | 394 | 0.270 |
Why?
|
| Genetic Markers | 2 | 2004 | 2604 | 0.270 |
Why?
|
| Inpatients | 1 | 2018 | 2570 | 0.270 |
Why?
|
| Research Design | 2 | 2023 | 6213 | 0.250 |
Why?
|
| Bibliometrics | 2 | 2023 | 355 | 0.250 |
Why?
|
| User-Computer Interface | 3 | 2012 | 1406 | 0.240 |
Why?
|
| Cooperative Behavior | 1 | 2011 | 1515 | 0.230 |
Why?
|
| Research Personnel | 3 | 2021 | 590 | 0.230 |
Why?
|
| Evidence-Based Medicine | 2 | 2013 | 3709 | 0.220 |
Why?
|
| Enoxaparin | 2 | 2017 | 391 | 0.220 |
Why?
|
| Faculty, Medical | 3 | 2017 | 1225 | 0.220 |
Why?
|
| Career Mobility | 2 | 2016 | 262 | 0.210 |
Why?
|
| Artificial Intelligence | 3 | 2018 | 2665 | 0.200 |
Why?
|
| Confidentiality | 3 | 2019 | 606 | 0.200 |
Why?
|
| Lymphatic System | 1 | 2024 | 251 | 0.200 |
Why?
|
| Genetics, Microbial | 1 | 2002 | 53 | 0.200 |
Why?
|
| Health Services Research | 1 | 2009 | 1818 | 0.190 |
Why?
|
| Sequence Alignment | 1 | 2005 | 2179 | 0.190 |
Why?
|
| Brain Neoplasms | 5 | 2023 | 9213 | 0.180 |
Why?
|
| Decision Making | 2 | 2013 | 3952 | 0.180 |
Why?
|
| Information Systems | 2 | 2014 | 400 | 0.180 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2004 | 3811 | 0.180 |
Why?
|
| Humans | 64 | 2024 | 768887 | 0.180 |
Why?
|
| Hospitalization | 6 | 2022 | 10845 | 0.170 |
Why?
|
| Computer Graphics | 1 | 2021 | 344 | 0.170 |
Why?
|
| Venous Thromboembolism | 3 | 2018 | 1880 | 0.170 |
Why?
|
| Boston | 5 | 2018 | 9375 | 0.160 |
Why?
|
| Anticoagulants | 4 | 2022 | 4850 | 0.160 |
Why?
|
| Delivery of Health Care | 4 | 2023 | 5375 | 0.150 |
Why?
|
| Chromosome Mapping | 2 | 2005 | 4624 | 0.150 |
Why?
|
| Phylogeny | 1 | 2005 | 2843 | 0.150 |
Why?
|
| National Institutes of Health (U.S.) | 3 | 2021 | 794 | 0.150 |
Why?
|
| Computer Security | 2 | 2021 | 260 | 0.140 |
Why?
|
| Academic Medical Centers | 4 | 2017 | 2784 | 0.140 |
Why?
|
| DNA Mutational Analysis | 1 | 2005 | 4123 | 0.140 |
Why?
|
| Evolution, Molecular | 1 | 2005 | 1894 | 0.140 |
Why?
|
| Sequence Analysis, DNA | 2 | 2005 | 4784 | 0.140 |
Why?
|
| Insurance Claim Reporting | 1 | 2017 | 166 | 0.140 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2018 | 344 | 0.140 |
Why?
|
| Disease | 1 | 2021 | 673 | 0.130 |
Why?
|
| Salicylates | 1 | 2016 | 128 | 0.130 |
Why?
|
| Physicians | 1 | 2013 | 4607 | 0.120 |
Why?
|
| Computational Biology | 3 | 2020 | 3562 | 0.110 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2023 | 2763 | 0.110 |
Why?
|
| Financing, Government | 1 | 2017 | 473 | 0.110 |
Why?
|
| Programming Languages | 1 | 2014 | 132 | 0.110 |
Why?
|
| Heart Failure | 1 | 2018 | 11879 | 0.110 |
Why?
|
| Intelligence | 2 | 2022 | 927 | 0.110 |
Why?
|
| Medical Subject Headings | 1 | 2013 | 16 | 0.110 |
Why?
|
| Organ Transplantation | 1 | 2023 | 1178 | 0.110 |
Why?
|
| Research Support as Topic | 1 | 2017 | 696 | 0.110 |
Why?
|
| Health Care Surveys | 2 | 2018 | 2437 | 0.100 |
Why?
|
| Retrospective Studies | 13 | 2023 | 81892 | 0.100 |
Why?
|
| Diagnostic Tests, Routine | 2 | 2021 | 790 | 0.100 |
Why?
|
| Information Seeking Behavior | 1 | 2014 | 116 | 0.100 |
Why?
|
| PubMed | 1 | 2013 | 130 | 0.100 |
Why?
|
| Information Services | 1 | 2014 | 239 | 0.100 |
Why?
|
| Publishing | 2 | 2021 | 837 | 0.100 |
Why?
|
| United States | 13 | 2021 | 73180 | 0.100 |
Why?
|
| Databases, Factual | 5 | 2021 | 8095 | 0.100 |
Why?
|
| Colonic Neoplasms | 1 | 2023 | 2543 | 0.090 |
Why?
|
| Research | 2 | 2023 | 1981 | 0.090 |
Why?
|
| Multivariate Analysis | 1 | 2004 | 12093 | 0.090 |
Why?
|
| Natural Language Processing | 1 | 2020 | 1203 | 0.090 |
Why?
|
| Databases, Genetic | 3 | 2009 | 1758 | 0.090 |
Why?
|
| Science | 1 | 2013 | 236 | 0.090 |
Why?
|
| Universities | 2 | 2014 | 1005 | 0.080 |
Why?
|
| Fractures, Compression | 1 | 2011 | 132 | 0.080 |
Why?
|
| Hospital Administration | 1 | 2013 | 353 | 0.080 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 3671 | 0.080 |
Why?
|
| Public Policy | 1 | 2013 | 552 | 0.080 |
Why?
|
| Gene Expression Profiling | 2 | 2004 | 9549 | 0.080 |
Why?
|
| Suicide | 1 | 2020 | 1606 | 0.080 |
Why?
|
| Genome, Human | 1 | 2002 | 4456 | 0.080 |
Why?
|
| Databases, Nucleic Acid | 1 | 2009 | 204 | 0.080 |
Why?
|
| Database Management Systems | 1 | 2010 | 263 | 0.080 |
Why?
|
| Fellowships and Scholarships | 1 | 2017 | 1134 | 0.080 |
Why?
|
| Medical Informatics | 2 | 2014 | 742 | 0.080 |
Why?
|
| Reproducibility of Results | 3 | 2021 | 20244 | 0.070 |
Why?
|
| Systems Integration | 1 | 2010 | 430 | 0.070 |
Why?
|
| Hospitals | 1 | 2021 | 3903 | 0.070 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2012 | 600 | 0.070 |
Why?
|
| Logistic Models | 1 | 2002 | 13317 | 0.070 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2277 | 0.070 |
Why?
|
| Molecular Biology | 1 | 2009 | 573 | 0.060 |
Why?
|
| Terminology as Topic | 1 | 2013 | 1541 | 0.060 |
Why?
|
| Genomics | 1 | 2021 | 5928 | 0.060 |
Why?
|
| PPAR gamma | 1 | 2008 | 487 | 0.060 |
Why?
|
| Expressed Sequence Tags | 2 | 2004 | 251 | 0.060 |
Why?
|
| Middle Aged | 13 | 2023 | 223740 | 0.060 |
Why?
|
| Models, Theoretical | 3 | 2013 | 3580 | 0.060 |
Why?
|
| Thiazolidinediones | 1 | 2008 | 461 | 0.060 |
Why?
|
| Overweight | 1 | 2016 | 2445 | 0.060 |
Why?
|
| Spinal Neoplasms | 1 | 2011 | 715 | 0.060 |
Why?
|
| Adult | 9 | 2023 | 223818 | 0.060 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2016 | 1550 | 0.060 |
Why?
|
| Climacteric | 1 | 2004 | 57 | 0.060 |
Why?
|
| Periodicals as Topic | 1 | 2016 | 1470 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2005 | 1057 | 0.060 |
Why?
|
| Spinal Fractures | 1 | 2011 | 712 | 0.060 |
Why?
|
| Stochastic Processes | 1 | 2005 | 360 | 0.060 |
Why?
|
| ROC Curve | 2 | 2022 | 3629 | 0.060 |
Why?
|
| Patient-Centered Care | 1 | 2014 | 1447 | 0.060 |
Why?
|
| Phenotype | 1 | 2021 | 16735 | 0.050 |
Why?
|
| Diagnosis | 1 | 2004 | 156 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 15955 | 0.050 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 5434 | 0.050 |
Why?
|
| Informatics | 1 | 2023 | 71 | 0.050 |
Why?
|
| Logical Observation Identifiers Names and Codes | 1 | 2022 | 16 | 0.050 |
Why?
|
| Gene Library | 2 | 2004 | 1062 | 0.050 |
Why?
|
| Quality Improvement | 1 | 2018 | 3856 | 0.050 |
Why?
|
| Conserved Sequence | 1 | 2005 | 1162 | 0.050 |
Why?
|
| Male | 13 | 2021 | 365249 | 0.050 |
Why?
|
| Electronics | 1 | 2023 | 317 | 0.050 |
Why?
|
| Female | 16 | 2021 | 397464 | 0.050 |
Why?
|
| Glioma | 1 | 2017 | 3532 | 0.050 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2011 | 1177 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2020 | 24330 | 0.050 |
Why?
|
| Bayes Theorem | 2 | 2020 | 2357 | 0.050 |
Why?
|
| Lung Neoplasms | 2 | 2022 | 13593 | 0.040 |
Why?
|
| Authorship | 1 | 2023 | 289 | 0.040 |
Why?
|
| Subtraction Technique | 1 | 2003 | 519 | 0.040 |
Why?
|
| Mental Disorders | 1 | 2020 | 6879 | 0.040 |
Why?
|
| Physician-Patient Relations | 1 | 2013 | 3269 | 0.040 |
Why?
|
| Neoplasms | 2 | 2015 | 22390 | 0.040 |
Why?
|
| Lymphatic Vessels | 1 | 2024 | 356 | 0.040 |
Why?
|
| Ethics Committees, Research | 1 | 2021 | 196 | 0.040 |
Why?
|
| Cluster Analysis | 2 | 2023 | 2730 | 0.040 |
Why?
|
| Aged | 7 | 2023 | 171790 | 0.040 |
Why?
|
| Gene Expression | 2 | 2002 | 7602 | 0.040 |
Why?
|
| RNA, Neoplasm | 1 | 2001 | 751 | 0.040 |
Why?
|
| Communication | 1 | 2013 | 3908 | 0.040 |
Why?
|
| Diabetic Retinopathy | 1 | 2008 | 1299 | 0.040 |
Why?
|
| Hormone Replacement Therapy | 1 | 2004 | 756 | 0.040 |
Why?
|
| Obesity | 2 | 2023 | 13087 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2011 | 8742 | 0.040 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2008 | 2059 | 0.040 |
Why?
|
| Viruses | 1 | 2002 | 373 | 0.040 |
Why?
|
| Genome, Viral | 1 | 2002 | 673 | 0.040 |
Why?
|
| Peer Review, Research | 1 | 2021 | 344 | 0.040 |
Why?
|
| Herpesvirus 4, Human | 1 | 2003 | 1082 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2012 | 9384 | 0.040 |
Why?
|
| Cohort Studies | 4 | 2024 | 41800 | 0.030 |
Why?
|
| Government Regulation | 1 | 2021 | 525 | 0.030 |
Why?
|
| Inflammation | 1 | 2016 | 10869 | 0.030 |
Why?
|
| DNA, Neoplasm | 1 | 2002 | 1748 | 0.030 |
Why?
|
| Genome | 1 | 2004 | 1752 | 0.030 |
Why?
|
| Pattern Recognition, Automated | 1 | 2022 | 998 | 0.030 |
Why?
|
| Registries | 1 | 2012 | 8384 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2005 | 17629 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2005 | 3446 | 0.030 |
Why?
|
| Prognosis | 4 | 2021 | 30044 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2008 | 3110 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2021 | 14751 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2002 | 2205 | 0.030 |
Why?
|
| Base Sequence | 1 | 2005 | 12430 | 0.030 |
Why?
|
| San Francisco | 1 | 2014 | 166 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2011 | 13020 | 0.030 |
Why?
|
| Retina | 1 | 2004 | 2661 | 0.030 |
Why?
|
| Organizations | 1 | 2014 | 172 | 0.030 |
Why?
|
| Vocabulary, Controlled | 1 | 2014 | 170 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2004 | 3613 | 0.030 |
Why?
|
| Awards and Prizes | 1 | 2017 | 365 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2022 | 10115 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2024 | 3473 | 0.030 |
Why?
|
| Efficiency | 1 | 2015 | 480 | 0.020 |
Why?
|
| Software Design | 1 | 2012 | 173 | 0.020 |
Why?
|
| Sex Ratio | 1 | 2012 | 107 | 0.020 |
Why?
|
| Aspirin | 1 | 2023 | 3135 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2005 | 5107 | 0.020 |
Why?
|
| Carcinoma | 1 | 2002 | 2340 | 0.020 |
Why?
|
| Mammography | 1 | 2002 | 2434 | 0.020 |
Why?
|
| Schools, Medical | 1 | 2017 | 882 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2018 | 4042 | 0.020 |
Why?
|
| Demography | 1 | 2015 | 1643 | 0.020 |
Why?
|
| Online Systems | 1 | 2011 | 182 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2004 | 12809 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2008 | 5892 | 0.020 |
Why?
|
| Incidence | 2 | 2018 | 21545 | 0.020 |
Why?
|
| Educational Status | 1 | 2016 | 2515 | 0.020 |
Why?
|
| Internal Medicine | 1 | 2015 | 1064 | 0.020 |
Why?
|
| Young Adult | 3 | 2023 | 60110 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2022 | 12563 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2020 | 9682 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 59738 | 0.020 |
Why?
|
| Databases, Protein | 1 | 2009 | 390 | 0.020 |
Why?
|
| Neurology | 1 | 2015 | 787 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2021 | 26394 | 0.020 |
Why?
|
| Adolescent | 3 | 2023 | 89247 | 0.020 |
Why?
|
| Thoracic Vertebrae | 1 | 2011 | 614 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 6546 | 0.020 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2011 | 709 | 0.020 |
Why?
|
| Systems Biology | 1 | 2009 | 482 | 0.020 |
Why?
|
| Risk Factors | 3 | 2018 | 74971 | 0.020 |
Why?
|
| Survival Rate | 2 | 2015 | 12873 | 0.020 |
Why?
|
| Infant | 2 | 2021 | 36541 | 0.020 |
Why?
|
| Anesthesiology | 1 | 2015 | 1137 | 0.020 |
Why?
|
| Breast Neoplasms | 2 | 2002 | 21187 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2021 | 42684 | 0.010 |
Why?
|
| Time Factors | 3 | 2018 | 40266 | 0.010 |
Why?
|
| Macular Edema | 1 | 2008 | 387 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2001 | 6401 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2004 | 310 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 39394 | 0.010 |
Why?
|
| General Surgery | 1 | 2015 | 1722 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 36861 | 0.010 |
Why?
|
| Sex Factors | 1 | 2017 | 10641 | 0.010 |
Why?
|
| Child | 3 | 2021 | 80969 | 0.010 |
Why?
|
| Psychiatry | 1 | 2015 | 1716 | 0.010 |
Why?
|
| Medical Records | 1 | 2008 | 1411 | 0.010 |
Why?
|
| Quality of Life | 1 | 2004 | 13510 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2016 | 12469 | 0.010 |
Why?
|
| Risk Reduction Behavior | 1 | 2008 | 1119 | 0.010 |
Why?
|
| Radiology | 1 | 2015 | 2104 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 3253 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 2008 | 1320 | 0.010 |
Why?
|
| Neoplasm Metastasis | 2 | 2002 | 4926 | 0.010 |
Why?
|
| Mathematics | 1 | 2002 | 704 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 2004 | 818 | 0.010 |
Why?
|
| North America | 1 | 2004 | 1290 | 0.010 |
Why?
|
| Markov Chains | 1 | 2004 | 979 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2004 | 1904 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 11262 | 0.010 |
Why?
|
| Pediatrics | 1 | 2015 | 3628 | 0.010 |
Why?
|
| Animals | 3 | 2009 | 169408 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2003 | 1990 | 0.010 |
Why?
|
| Interneurons | 1 | 2004 | 593 | 0.010 |
Why?
|
| Carcinoma, Small Cell | 1 | 2001 | 419 | 0.010 |
Why?
|
| Mitosis | 1 | 2004 | 1181 | 0.010 |
Why?
|
| Neuroglia | 1 | 2004 | 960 | 0.010 |
Why?
|
| Visual Acuity | 1 | 2008 | 2714 | 0.010 |
Why?
|
| Disease Progression | 2 | 2008 | 13677 | 0.010 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2012 | 2445 | 0.010 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2004 | 1741 | 0.010 |
Why?
|
| Life Expectancy | 1 | 2004 | 1249 | 0.010 |
Why?
|
| Comorbidity | 1 | 2012 | 10591 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2015 | 22294 | 0.010 |
Why?
|
| Prevalence | 1 | 2012 | 15875 | 0.010 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2002 | 1093 | 0.010 |
Why?
|
| Decision Support Techniques | 1 | 2004 | 2008 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2002 | 3629 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2003 | 6085 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2008 | 3447 | 0.010 |
Why?
|
| Models, Biological | 1 | 2009 | 9499 | 0.010 |
Why?
|
| Mortality | 1 | 2004 | 2915 | 0.010 |
Why?
|
| Risk | 1 | 2004 | 9621 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 65485 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2008 | 14795 | 0.010 |
Why?
|
| Stem Cells | 1 | 2004 | 3540 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2016 | 54950 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2004 | 11934 | 0.000 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2001 | 4064 | 0.000 |
Why?
|
| Mass Screening | 1 | 2002 | 5455 | 0.000 |
Why?
|
| Smoking | 1 | 2001 | 9094 | 0.000 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2008 | 12252 | 0.000 |
Why?
|
| Mice | 1 | 2004 | 82074 | 0.000 |
Why?
|